An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.
about
Serum-derived exosomes from non-viremic animals previously exposed to the porcine respiratory and reproductive virus contain antigenic viral proteins.Harnessing Local Immunity for an Effective Universal Swine Influenza VaccineEntrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditionsRespiratory nanoparticle-based vaccines and challenges associated with animal models and translationComparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.Assessment of the efficacy of two novel DNA vaccine formulations against highly pathogenic Porcine Reproductive and Respiratory Syndrome Virus.Mutations in a Highly Conserved Motif of nsp1β Protein Attenuate the Innate Immune Suppression Function of Porcine Reproductive and Respiratory Syndrome Virus.Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.Improved Vaccine against PRRSV: Current Progress and Future Perspective.Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses.Nonstructural proteins nsp2TF and nsp2N of porcine reproductive and respiratory syndrome virus (PRRSV) play important roles in suppressing host innate immune responses.Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs
P2860
Q27321003-B99EE5EB-4C64-4641-9F9D-902B3A8C0E19Q30234558-95E0542F-9FCE-480A-A2D7-CD5E3EE3B4D3Q30387075-80751D68-5A9E-4098-8D8C-D91A70A8C952Q36424830-34F7F386-80F9-41E1-81D5-B57AB002A522Q36598433-C191B6E9-A3D6-4F82-8742-AFA479B3D70EQ36700988-10B1FE8F-23C9-4714-9CC9-CE348F321A44Q37623519-6EEDC34A-D9B5-4B9C-9B52-23A6C6582FB2Q38801171-E38374B0-FD77-4C25-B842-D81B44B26E0DQ47137438-6E149F4B-B3E1-4D58-8743-F3F7221934E4Q47154824-6B1F658E-B468-414B-9DFE-CBCCBCE1AB13Q50031504-3836E9EE-BC03-441B-A03B-573EDC2C8A8AQ55357132-8B08A6D8-068C-4050-A54E-FD7330EA144FQ58698634-40049C71-3A43-4B67-8BC0-E56A3EA15FC2
P2860
An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An innovative approach to indu ...... otechnology-based vaccination.
@en
An innovative approach to indu ...... otechnology-based vaccination.
@nl
type
label
An innovative approach to indu ...... otechnology-based vaccination.
@en
An innovative approach to indu ...... otechnology-based vaccination.
@nl
prefLabel
An innovative approach to indu ...... otechnology-based vaccination.
@en
An innovative approach to indu ...... otechnology-based vaccination.
@nl
P2093
P2860
P356
P1476
An innovative approach to indu ...... otechnology-based vaccination.
@en
P2093
Basavaraj Binjawadagi
Cordelia Manickam
Gourapura J Renukaradhya
Jordi B Torrelles
Kang Ouyang
Varun Dwivedi
P2860
P304
P356
10.2147/IJN.S59924
P407
P577
2014-03-24T00:00:00Z